Cancer Investigation
Predictive Value of the High-Sensitivity C-Reactive Protein/HDL-Cholesterol Ratio for Cardiovascular and Cancer-Specific Mortality in Cancer Survivors: A Study from NHANES 2015-2018
Cohort study of 1,064 peopleBiomarkers
61 months
- C-reactive protein
- HDL cholesterol
- Cancer
- Cardiovascular disease
- High-sensitivity C-reactive protein/high-density lipoprotein cholesterol ratio
- Humans
The paper
Wuhan Puai Hospital; Tongji Hospital
Cancer Investigation, 24 Aug 2026
